You have 9 free searches left this month | for more free features.

campath

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

Completed
  • Hodgkin Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Campath
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022

Kidney Transplantation, Kidney Diseases, Kidney Failure Trial in London (Campath, Daclizumab)

Completed
  • Kidney Transplantation
  • +2 more
  • London, United Kingdom
    West London Renal and Transplant Centre, 4th Floor Ham House, Ha
Sep 1, 2021

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

Completed
  • Mycosis Fungoides
  • Sezary Syndrome
  • A matched peripheral donor stem cells
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for

Withdrawn
  • Scleroderma
  • Campath
  • Los Angeles, California
    Childrens Hospitla Los Angeles
Jan 5, 2019

Leukemia, Lymphoma, Myeloma Trial in Chicago (Busulfan, Fludarabine, Campath)

Completed
  • Leukemia
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Feb 1, 2019

Leukemia Trial in Portland (drug, radiation, other)

Terminated
  • Leukemia
  • Campath
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 25, 2017

Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

Completed
  • Acute Myelogenous Leukemia
  • +8 more
  • Chicago, Illinois
    The University of Chicago
Oct 7, 2016

Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

Terminated
  • Myelodysplastic and Myeloproliferative Disorders
  • +7 more
  • Campath
  • +4 more
  • Houston, Texas
  • +1 more
Mar 29, 2016

Aplastic Anemia Trial in Houston (drug, radiation, procedure)

Terminated
  • Aplastic Anemia
  • Houston, Texas
  • +1 more
Mar 24, 2016

Chronic Lymphocytic Leukemia Trial in New Hyde Park (Campath)

Terminated
  • Chronic Lymphocytic Leukemia
  • Campath
  • New Hyde Park, New York
    Long Island Jewish Medical Center
Sep 16, 2015

Systemic Lupus Erythematosus, Systemic Sclerosis Trial in New York (Reduced Intensity Allogeneic Transplant, Fludarabine,

Terminated
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Reduced Intensity Allogeneic Transplant
  • +3 more
  • New York, New York
    Columbia University Medical Center
Feb 6, 2014

Advanced Hematologic Malignancies, Leukemia, Preleukemia Trial in Chicago (Clofarabine, Melphalan, Campath)

Completed
  • Advanced Hematologic Malignancies
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Jan 9, 2014

Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)

Terminated
  • Preleukemia
  • +4 more
  • Chicago, Illinois
    The Uniiversity of Chicago
Mar 14, 2014

Leukemia Trial in Italy (Fludarabine, Campath, Transplant)

Completed
  • Leukemia
  • Alessandria, Italy
  • +22 more
Aug 20, 2013

Leukemia Trial in Rouen (Campath, rituximab, cyclophosphamide)

Completed
  • Leukemia
  • Campath
  • +3 more
  • Rouen, France
    Centre Henri Becquerel
Jul 24, 2013

Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)

Terminated
  • Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 8, 2011